Life Sciences Now

Scientist granted U.S. patent for fraudulent stem cell research

Posted on February 21st, by Michael Shapiro-Barr

Korean researcher Hwang Woo-suk, who was fired from his university and convicted of criminal charges for fraudulent stem cell research, has been awarded a U.S. patent for the discredited research.   Woo-suk had claimed to have extracted a stem cell line from cloned human embryos, which could be used to treat diseases in the patient from which the stem cell line was cloned.  In 2006, a panel at Woo-suk’s university concluded that his research was fraudulent.

The patent covers a human embryonic stem cell line derived from cloning and the method used for obtaining the cells, with a condition that Woo-suk agree to make the cell line available for other researchers to investigate.

Read More



Comments are closed.

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Media Quotes

  • Mercedes Meyer, a patent lawyer with the firm Drinker Biddle in Washington, D.C., said the Supreme Court’s failure to provide “bright-line guidance”—a ruling that would settle once-and-for all whether patent settlements are legal or not—means there’s “really no difference now than what was going on.” Mercedes Meyer
    CNBC: High Court Allows FTC to Challenge 'Pay-to-Delay' Generics

From the Blog

President Issues Sanctions to Support Stability in Ukraine

Today, March 6, 2014, President Obama signed a new Executive Order in response to the threats Ukraine is facing to its peace and stability....

New Reprint Guidance Maintains Bipartisan Status Quo

On February 28, 2014, the FDA issued its most recent unofficial guidance on distribution by manufacturers of research concerning off-label uses.  With minor textual revisions,...

High Court Should Reverse 4th Circ.’s Flawed FCA Ruling

The U.S. Supreme Court is currently deciding whether to review the Fourth Circuit’s decision in United States ex rel. Carter v. Halliburton Co., 710...